Visiting professor at Tokyo Medical University, Japan
Jiro Akimoto, born in Tokyo, Japan, on March 5, 1961, is a distinguished neurosurgeon currently serving as a Professor in the Department of Neurosurgery at Tokyo Medical University. With over three decades of experience in neurosurgery, he holds a leadership position as Vice President and Director of the Department of Neurosurgery at Kohsei Chuo General Hospital. Renowned for his contributions to brain tumor treatment, Dr. Akimoto has significantly advanced the field of neurosurgery in Japan.
Profile
ORCID
Strengths for the Award
- Extensive Academic and Clinical Experience
Dr. Akimoto’s career spans over three decades in neurosurgery, with prestigious positions such as Professor at Tokyo Medical University and Vice President at Kohsei Chuo General Hospital. His leadership roles and responsibility as Chairman of the Department of Neurosurgery demonstrate a high level of expertise and influence in his field.
- Research Contributions
Dr. Akimoto has made significant contributions to neurosurgery, especially in the area of brain tumor pathology and laser surgery. His D.M.Sci. thesis on glutamine synthetase expression indicates a focus on pioneering research related to brain tumors, a field with profound clinical implications.
- Recognition and Awards
He has been recognized with several prestigious awards, including the Pfizer Award (2017, 2021) and multiple Best Research Awards from leading societies like the Japan Society of Laser Surgery and Medicine. These accolades reflect the impact and relevance of his work within the scientific community.
- Editorial and Review Roles
Dr. Akimoto serves as an editor and reviewer for several leading journals, such as Brain Tumor Pathology and Translational Neuro Oncology. His engagement in the editorial process is an indicator of his expertise and respected standing in the academic world.
- Professional Society Leadership
His roles as Councilor and Director in numerous professional societies, including the Japan Neurosurgical Society and the Japan Society of Laser Surgery and Medicine, underscore his leadership and influence in shaping the future direction of neurosurgery research and practice.
- Pioneering in Laser Surgery
Dr. Akimoto’s focus on laser surgery and his recognition by relevant societies point to his efforts in advancing this minimally invasive technique, which holds great promise for reducing patient recovery times and improving surgical outcomes.
Education🎓
Dr. Akimoto earned his M.D. in 1986 from the Faculty of Medicine at Tokyo Medical University. He pursued further specialization with postdoctoral training at both the University of Tokyo and Tokyo Medical University. In 1993, he completed his D.M.Sci. degree with a focus on the immunohistochemical study of glutamine synthetase expression in normal brain and brain tumors.
Experience👨‍⚕️
With a career spanning multiple esteemed institutions, Dr. Akimoto’s early work included roles as a Clinical and Research Assistant and Research Fellow at Tokyo Medical University and the University of Tokyo. He has held various leadership roles, including Head of the Department of Neurosurgery at Tanashi Dai-ichi Hospital, and Assistant Professor at Tokyo Medical University before becoming a full Professor in 2015. Since 2018, he has been the Chairman and Director of Neurosurgery at Kohsei Chuo General Hospital, rising to Vice President in 2022.
Research Interest🔬
Dr. Akimoto’s research primarily focuses on neurosurgery and brain tumor treatment. His investigations into brain tumor pathology, photodynamic therapy, and laser surgery are widely recognized in academic and clinical communities. He has made notable contributions to understanding glutamine synthetase in brain tumors, which has enhanced therapeutic approaches and patient outcomes.
Awards🏅Â
Throughout his career, Dr. Akimoto has received several prestigious awards, including the Best Research Award from the Japan Society of Laser Surgery and Medicine in 2012, 2014, and 2021. Additionally, he was honored with the Pfizer Award by the Japanese Society of Toxicology in 2017 and 2021 for his groundbreaking research contributions.
Publicationsđź“šÂ
Dr. Akimoto has contributed extensively to medical literature, with his research being published in top-tier journals. Notable works include:
- “Cytocidal Effects of Interstitial Photodynamic Therapy Using Talaporfin Sodium and a Semiconductor Laser in a Rat Intracerebral Glioma Model”
- Published in: Biomedicines
- Year: 2024 (published in September 2024)
- DOI: 10.3390/biomedicines12092141
- Authors: Yuki Saito, Shinjiro Fukami, Kenta Nagai, Emiyu Ogawa, Masahiko Kuroda, Michihiro Kohno, Jiro Akimoto​
​
.
- “First Clinical Report of the Intraoperative Macro- and Micro-Photodiagnosis and Photodynamic Therapy Using Talaporfin Sodium for a Patient with Disseminated Lumbar Medulloblastoma”
- Published in: Journal of Clinical Medicine
- Year: 2023 (January 2023)
- DOI: 10.3390/jcm12020432
- Authors: Jiro Akimoto, Shinjiro Fukami, Kenta Nagai, Michihiro Kohno​
.
- “Preliminary Report: Rapid Intraoperative Detection of Residual Glioma Cell in Resection Cavity Walls Using a Compact Fluorescence Microscope”
- Published in: Journal of Clinical Medicine
- Year: 2021 (November 2021)
- DOI: 10.3390/jcm10225375
- Authors: Jiro Akimoto, Shinjiro Fukami, Megumi Ichikawa, Kenta Nagai, Michihiro Kohno​
Conclusion✍️
Dr. Jiro Akimoto is an eminent figure in the field of neurosurgery, known for his leadership, clinical expertise, and dedication to advancing brain tumor treatment. His achievements have not only earned him prestigious awards but also established him as a highly respected researcher and professor in the medical community. His contributions continue to influence both the academic and clinical spheres of neurosurgery.